Conclusion Of Non-Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8/130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Olanzapine (N05Ah03), Without Solid Oral Dosage Forms As Part Of A So-Called Open-House Model.

  Address - Germany

  Contact details - 565656565

  Tender notice no. - 76454545

  MT Ref Id - 93382155

  Document Type - Tender Notices

Description - Description: Conclusion of non-exclusive discount agreements in accordance with Section 130a Paragraph 8/130c Paragraph 1 SGB V for medicinal products containing the active ingredient olanzapine (N05AH03), without solid oral dosage forms, within the period from November 1, 2024 to October 31, 2026 with the possibility of concluding the contract at any time (open-house model). In the open house procedure, medicinal products in accordance with the BfArM list in accordance with Section 35 Paragraph 5a SGB V (medicines for children) are excluded.notice_title: Conclusion Of Non-Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8/130C Paragraph 1 Sgb V For Medicinal Products Contain

Mt Ref Id - 93382155

Deadline - Aug 31, 2026